419 related articles for article (PubMed ID: 24823966)
1. Comparison of inflammation-based prognostic scores as predictors of tumor recurrence in patients with hepatocellular carcinoma after curative resection.
Yamamura K; Sugimoto H; Kanda M; Yamada S; Nomoto S; Nakayama G; Fujii T; Koike M; Fujiwara M; Kodera Y
J Hepatobiliary Pancreat Sci; 2014 Sep; 21(9):682-8. PubMed ID: 24823966
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of preoperative aspartate aminotransferase to neutrophil ratio index in patients with hepatocellular carcinoma after hepatic resection.
Ji F; Fu S; Guo Z; Pang H; Chen D; Wang X; Ju W; Wang D; He X; Hua Y; Peng B
Oncotarget; 2016 Nov; 7(44):72276-72289. PubMed ID: 27472390
[TBL] [Abstract][Full Text] [Related]
3. A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI).
Ji F; Liang Y; Fu SJ; Guo ZY; Shu M; Shen SL; Li SQ; Peng BG; Liang LJ; Hua YP
BMC Cancer; 2016 Feb; 16():137. PubMed ID: 26907597
[TBL] [Abstract][Full Text] [Related]
4. Preoperative neutrophil to lymphocyte ratio and prognostic nutritional index predict overall survival after hepatectomy for hepatocellular carcinoma.
Okamura Y; Ashida R; Ito T; Sugiura T; Mori K; Uesaka K
World J Surg; 2015 Jun; 39(6):1501-9. PubMed ID: 25670038
[TBL] [Abstract][Full Text] [Related]
5. Preoperative inflammation-based markers predict early and late recurrence of hepatocellular carcinoma after curative hepatectomy.
Liu Y; Wang ZX; Cao Y; Zhang G; Chen WB; Jiang CP
Hepatobiliary Pancreat Dis Int; 2016 Jun; 15(3):266-74. PubMed ID: 27298102
[TBL] [Abstract][Full Text] [Related]
6. The Impact of Serosal Invasion on Prognosis after Curative Hepatectomy for Hepatocellular Carcinoma: Invasion to Adjacent Organs and Rupture of Tumor Were Crucial Tumor-Related Prognostic Factors Needed for Survival.
Kato Y; Okamura Y; Sugiura T; Ito T; Yamamoto Y; Ashida R; Uesaka K
Dig Surg; 2018; 35(2):155-163. PubMed ID: 28787731
[TBL] [Abstract][Full Text] [Related]
7. Significance of neutrophil-to-lymphocyte ratio, platelet-to-lymphocyte ratio and prognostic nutrition index as preoperative predictors of early mortality after liver resection for huge (≥10 cm) hepatocellular carcinoma.
Goh BK; Kam JH; Lee SY; Chan CY; Allen JC; Jeyaraj P; Cheow PC; Chow PK; Ooi LL; Chung AY
J Surg Oncol; 2016 May; 113(6):621-7. PubMed ID: 26861568
[TBL] [Abstract][Full Text] [Related]
8. Lymphocyte to monocyte ratio and prognostic nutritional index predict survival outcomes of hepatitis B virus-associated hepatocellular carcinoma patients after curative hepatectomy.
Wu SJ; Lin YX; Ye H; Li FY; Xiong XZ; Cheng NS
J Surg Oncol; 2016 Aug; 114(2):202-10. PubMed ID: 27199001
[TBL] [Abstract][Full Text] [Related]
9. Neutrophil to lymphocyte ratio changes predict small hepatocellular carcinoma survival.
Peng W; Li C; Wen TF; Yan LN; Li B; Wang WT; Yang JY; Xu MQ
J Surg Res; 2014 Dec; 192(2):402-8. PubMed ID: 24998425
[TBL] [Abstract][Full Text] [Related]
10. Importance of tumor size as a prognostic factor after partial liver resection for solitary hepatocellular carcinoma: Implications on the current AJCC staging system.
Goh BK; Teo JY; Chan CY; Lee SY; Jeyaraj P; Cheow PC; Chow PK; Ooi LL; Chung AY
J Surg Oncol; 2016 Jan; 113(1):89-93. PubMed ID: 26611492
[TBL] [Abstract][Full Text] [Related]
11. Postoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio predicts the outcomes of hepatocellular carcinoma.
Li C; Wen TF; Yan LN; Li B; Wang WT; Yang JY; Xu MQ
J Surg Res; 2015 Sep; 198(1):73-9. PubMed ID: 26022997
[TBL] [Abstract][Full Text] [Related]
12. Serosal invasion strongly associated with recurrence after curative hepatic resection of hepatocellular carcinoma: a retrospective study of 214 consecutive cases.
Sonohara F; Nomoto S; Inokawa Y; Kanda M; Yamada S; Fujii T; Sugimoto H; Kodera Y
Medicine (Baltimore); 2015 Mar; 94(9):e602. PubMed ID: 25738484
[TBL] [Abstract][Full Text] [Related]
13. Inflammation-based Prognostic Score in Patients with Living Donor Liver Transplantation for Hepatocellular Carcinoma.
Harimoto N; Yoshizumi T; Shimagaki T; Nagatsu A; Motomura T; Harada N; Okabe H; Itoh S; Ikegami T; Uchiyama H; Soejima Y; Maehara Y
Anticancer Res; 2016 Oct; 36(10):5537-5542. PubMed ID: 27798927
[TBL] [Abstract][Full Text] [Related]
14. Prognostic Nutritional Index (PNI) Predicts Tumor Recurrence of Very Early/Early Stage Hepatocellular Carcinoma After Surgical Resection.
Chan AW; Chan SL; Wong GL; Wong VW; Chong CC; Lai PB; Chan HL; To KF
Ann Surg Oncol; 2015 Dec; 22(13):4138-48. PubMed ID: 25801356
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the prognostic value of inflammation-based scores in early recurrent hepatocellular carcinoma after hepatectomy.
Wang C; He W; Yuan Y; Zhang Y; Li K; Zou R; Liao Y; Liu W; Yang Z; Zuo D; Qiu J; Zheng Y; Li B; Yuan Y
Liver Int; 2020 Jan; 40(1):229-239. PubMed ID: 31652394
[TBL] [Abstract][Full Text] [Related]
16. Lymphocyte to monocyte ratio and neutrophil to lymphocyte ratio are superior inflammation-based predictors of recurrence in patients with hepatocellular carcinoma after hepatic resection.
Yang T; Zhu J; Zhao L; Mai K; Ye J; Huang S; Zhao Y
J Surg Oncol; 2017 May; 115(6):718-728. PubMed ID: 28127774
[TBL] [Abstract][Full Text] [Related]
17. Selection criteria for repeat hepatectomy in patients with recurrent hepatocellular carcinoma.
Minagawa M; Makuuchi M; Takayama T; Kokudo N
Ann Surg; 2003 Nov; 238(5):703-10. PubMed ID: 14578733
[TBL] [Abstract][Full Text] [Related]
18. Stratified neutrophil-to-lymphocyte ratio accurately predict mortality risk in hepatocellular carcinoma patients following curative liver resection.
Huang GQ; Zhu GQ; Liu YL; Wang LR; Braddock M; Zheng MH; Zhou MT
Oncotarget; 2016 Feb; 7(5):5429-39. PubMed ID: 26716411
[TBL] [Abstract][Full Text] [Related]
19. Preoperative platelet-to-lymphocyte ratio is a valuable prognostic biomarker in patients with hepatocellular carcinoma undergoing curative liver resection.
Yang HJ; Jiang JH; Liu QA; Zhou CM; Du YF; Wu T; Chen NZ; Xiang BD
Tumour Biol; 2017 Jun; 39(6):1010428317707375. PubMed ID: 28639906
[TBL] [Abstract][Full Text] [Related]
20. Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101.
He CB; Lin XJ
PLoS One; 2017; 12(3):e0174769. PubMed ID: 28355305
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]